570 556 captures · dernière capture : 3 mai 2026
Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.
Explorateur d’archives
Parcourir et rechercher des captures
Note importante
Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.
Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.
Parcourir les sites archivés
386 223 captures · dernière capture : 14 avr. 2026
243 880 captures · dernière capture : 28 avr. 2026
Licensed Natural Health Products Database (LNHPD) - User Guide March 2017 - Version 1.1 The following document provides guidance to individuals wishing to search for licensed natural health products using the Licensed Natural Health Products Database (LNHPD). Users should note…
COVID-19 Disinfectants and sanitizers Information about disinfectants and sanitizers for manufacturers and distributors in relation to COVID-19. Services and information Hard surface disinfectants and hand sanitizers Regulatory response, expedited licensing, quality requirements,…
Product Licensing The Natural Health Products Directorate (NHPD) has changed its name to the Natural and Non-prescription Health Products Directorate (NNHPD) subsequent to its recently expanded mandate to include the oversight of non-prescription and disinfectant drugs in…
Applications and Submissions As per the Natural Health Products Regulations , product and site licences are required before a natural health product can be marketed in Canada. This section explains what applications and submissions are required to meet the requirements of the…
Notice: Clarifications Regarding Access to Restricted Drugs through the Special Access Program (SAP) Date: July 23, 2021 Our file number: 21-113500-270 Key messages Health Canada has proposed regulatory amendments that would restore potential access to restricted drugs Footnote 1…
Special Access Program for drugs: Guidance document for industry and practitioners Download the alternative format (PDF format, 397 KB, 29 pages) Date published: 2020-10-14 Revised date: 2022-04-11 This guidance document explains the regulatory information requirements and…
Adverse Reaction Reporting for Specific Products If you are currently suffering from a side effect - also known as an adverse reaction - you should contact your health care provider, your local health authority, or the Canadian Association of Poison Control Centres . Who can…
Media Room If you are a journalist and you cannot find what you are looking for, please contact our media relations team . All questions from the general public should be directed to our general inquiries centre. In the News Advisories, Warnings and Recalls News Related Resources…
Avis et mises en garde Santé Canada diffuse des communiqués ponctuels sur les questions d'intérêt pour la santé des Canadiens. La Base de données sur les rappels et les avis de sécurité vous permet d'obtenir facilement une liste complète des rappels, des avis et des alertes de…
Compliance and Enforcement: Assisted Human Reproduction The Regulatory Operations and Enforcement Branch of Health Canada is responsible for compliance and enforcement activities related to the Assisted Human Reproduction Act (the AHR Act) and its Regulations. On this page The…
Version préliminaire : la couverture et les fonctionnalités sont encore en expansion.
